Revolutions Medical Exhibits at 2011 HIDA Conference & Expo


CHARLESTON, S.C., Oct. 19, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation (OTCQB:RMCP) ("Revolutions Medical" or the "Company") is showcasing its 3ml RevVac safety syringe at the 2011 Health Industry Distributor Association (HIDA) Conference, October 19th through October 21st in Charlotte, North Carolina. Since 1902, HIDA has represented medical product distributors, providing networking and leadership forums.  Member benefits include regulatory updates, strategic information, and quality education, which allow member companies to perform profitably within today's complex healthcare supply chain.  There will be approximately 160 exhibitors with several thousand customers and guests expected to attend this event.

Revolutions Medical's 3ml RevVac safety syringe is an auto-retractable vacuum safety syringe which features numerous advantages over its competition, including ease of use, one-handed activation, lower disposable costs and the virtual elimination of accidental needle sticks where they predominately occur. The RevVac safety syringe also reduces the spread of contagious blood borne diseases through the reuse of contaminated needles.  Once the RevVac vacuum safety feature is activated, it cannot be reused and the needle is retracted and contained within the plunger.

For more information on the conference or if you would like to register to attend, please visit their website: www.hidamedsurg.com

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™ and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).

For additional information, please visit Revolutions Medical corporate website:

www.revolutionsmedical.com

To be added to the Revolutions Medical investor email list, please email:

investment@revolutionsmedical.com with RMCP in the subject line.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.



            

Coordonnées